Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2020

Nov 12, 2020

31996_dirs_2020-11-12_01f44d50-aecf-4115-9575-18217ffcdae2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2020-09-09

Reporting Person: Moore John C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-09 Common Stock M 5000 $10.31 Acquired 7117 Direct
2020-11-09 Common Stock M 10000 $15.73 Acquired 17117 Direct
2020-11-09 Common Stock M 1206 $16.15 Acquired 18323 Direct
2020-11-09 Common Stock D 16206 $81.03 Disposed 2117 Direct
2020-11-09 Common Stock D 14254 $80.88 Disposed 11387 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-09 Common Stock Options $10.31 M 5000 Disposed 2022-05-13 Common Stock (5000) Direct
2020-11-09 Common Stock Options $15.73 M 10000 Disposed 2024-06-08 Common Stock (10000) Direct
2020-11-09 Common Stock Options $16.15 M 1206 Disposed 2028-03-14 Common Stock (1206) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $82.16, inclusive.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $81.79, inclusive.